Proven Track Record Globally Across All Trial Phases
Our work in the cardiology and cardiovascular therapy areas includes studies on stents, artificial valve replacements, hypotension, hypertension, cardiomyopathy, ischemic heart disease, angina and exercise studies. These studies have involved numerous different therapy types, from aspirin and diuretics, to beta-blockers, ACE inhibitors and calcium antagonists, to numerous lipid lowering agents.
Illingworth has experience in cardiology trials from Phase I to Phase IV as well as Post Marketing studies, in a range of study types. This includes, but is not exclusive to: interventional, PK/PD models, observational and specialist orphan indications models.
We have successfully supported the smooth completion of cardiovascular studies in the UK, Europe, US, Canada and Australia. Our successes are partly due to our wonderful research nurses and partners in trying to offer the best possible patient experience.